Edition:
India

People: Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

5.20USD
25 Nov 2020
Change (% chg)

$0.25 (+5.05%)
Prev Close
$4.95
Open
$4.95
Day's High
$5.27
Day's Low
$4.94
Volume
105,599
Avg. Vol
228,267
52-wk High
$7.69
52-wk Low
$2.21

Skarpelos, Athanasios 

Mr. Athanasios Skarpelos serves as Independent Director of the Company. He is a self-employed investor with 20 years of experience working with private and public companies. For more than 12 years, he has been focused on biotechnology companies involved in drug discovery and drug development projects. His experience has led to relationships with researchers at academic institutes in Europe and North America. Mr. Skarpelos is a founder of Anavex.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 93,871
Fiscal Year Total, USD 93,871

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --